Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes

Nature Cell Biology

Volumn 18, Issue 7, 2016, Pages 814-821

  Van Ree, Janine H ^a   Nam, Hyun Ja ^a   Jeganathan, Karthik B ^a   Kanakkanthara, Arun ^a   Van Deursen, Jan M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; KINESIN; PDZ PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN DLG1; PROTEIN EG5; PROTEIN KINASE B; UNCLASSIFIED DRUG; DLG1 PROTEIN, HUMAN; EG5 PROTEIN, MOUSE; KIF11 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; PTEN PROTEIN, HUMAN; PTEN PROTEIN, MOUSE; SAPAP PROTEINS; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANEUPLOIDY; ARTICLE; BINDING AFFINITY; CELL CYCLE G2 PHASE; CELL MOTILITY; CENTROSOME; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; GENE LOCUS; HETEROZYGOSITY; HOMOZYGOSITY; LYMPHOCYTE; METAPHASE; MICROTUBULE; MITOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROPHASE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SPINDLE CELL; ANIMAL; CELL CYCLE; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SPINDLE POLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL CYCLE; CENTROSOME; HUMANS; KINESIN; MEMBRANE PROTEINS; MICE; MITOSIS; NERVE TISSUE PROTEINS; PTEN PHOSPHOHYDROLASE; SPINDLE POLES;

EID: 84973149519     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3369     Document Type: Article

References (40)

1. Chalhoub N, & Baker S. J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 4, 127-150 (2008).
2. Song M. S, Salmena L, & Pandolfi P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
3. Bonifant C. L, Kim J. S, & Waldman T. NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN. J. Cell Biochem. 102, 878-885 (2007).
4. Blangy A, et al. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83, 1159-1169 (1995).
5. Baker D. J, Jin F, Jeganathan K. B, & van Deursen J. M. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16, 475-486 (2009).
6. Kawabata T, et al. Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol. Cell 41, 543-553 (2011).
7. Ramaswamy S, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl Acad. Sci. USA 96, 2110-2115 (1999).
8. Kohn A. D, Takeuchi F, & Roth R. A. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271, 21920-21926 (1996).
9. Knafo S, et al. PTEN recruitment controls synaptic and cognitive function in Alzheimers models. Nat. Neurosci. 19, 443-453 (2016).
10. Bassi C, et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 341, 395-399 (2013).
11. Shen W. H, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157-170 (2007).
12. Nam H. J, & van Deursen J. M. Cyclin B2 and p53 control proper timing of centrosome separation. Nat. Cell Biol. 16, 538-549 (2014).
13. Silkworth W. T, Nardi I. K, Paul R, Mogilner A, & Cimini D. Timing of centrosome separation is important for accurate chromosome segregation. Mol. Biol. Cell 23, 401-411 (2012).
14. Saadaoui M, et al. Dlg1 controls planar spindle orientation in the neuroepithelium through direct interaction with LGN. J. Cell Biol. 206, 707-717 (2014).
15. Cross R. A, & McAinsh A. Prime movers: the mechanochemistry of mitotic kinesins. Nat. Rev. Mol. Cell Biol. 15, 257-271 (2014).
16. Mayer T. U, et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971-974 (1999).
17. Leonard M. K, Hill N. T, Bubulya P. A, & Kadakia M. P. The PTEN-Akt pathway impacts the integrity and composition of mitotic centrosomes. Cell Cycle 12, 1406-1415 (2013).
18. Choi B. H, Pagano M, & Dai W. Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle. J. Biol. Chem 289, 14066-14074 (2014).
19. Choi B. H, Pagano M, Huang C, & Dai W. Cdh1, a substrate-recruiting component of anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3 ligase, specifically interacts with phosphatase and tensin homolog (PTEN) and promotes its removal from chromatin. J. Biol. Chem 289, 17951-17959 (2014).
20. Song M. S, et al. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144, 187-199 (2011).
21. Mardin B. R, & Schiebel E. Breaking the ties that bind: new advances in centrosome biology. J. Cell Biol. 197, 11-18 (2012).
22. Bruinsma W, Raaijmakers J. A, & Medema R. H. Switching Polo-like kinase-1 on and off in time and space. Trends Biochem. Sci. 37, 534-542 (2012).
23. Vazquez F, Ramaswamy S, Nakamura N, & Sellers W. R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell Biol. 20, 5010-5018 (2000).
24. Smith E, et al. Differential control of Eg5-dependent centrosome separation by Plk1 and Cdk1. EMBO J. 30, 2233-2245 (2011).
25. Bertran M. T, et al. Nek9 is a Plk1-Activated kinase that controls early centrosome separation through Nek6/7 and Eg5. EMBO J. 30, 2634-2647 (2011).
26. Harris A. W, et al. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167, 353-371 (1988).
27. Johnson L, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
28. Di Cristofano A, Pesce B, Cordon-Cardo C, & Pandolfi P. P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355 (1998).
29. Whang Y. E, et al. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl Acad. Sci. USA 95, 5246-5250 (1998).
30. Papa A, et al. Cancer-Associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157, 595-610 (2014).
31. Sun Z, et al. PTEN C-terminal deletion causes genomic instability and tumor development. Cell Rep. 6, 844-854 (2014).
32. Holland A. J, & Cleveland D. W. Losing balance: the origin and impact of aneuploidy in cancer. EMBO Rep. 13, 501-514 (2012).
33. Tang S. H, Silva F. J, Tsark W. M, & Mann J. R. A Cre/loxP-deleter transgenic line in mouse strain 129S1/SvImJ. Genesis 32 199-202 (2002).
34. Jeganathan K, Malureanu L, Baker D. J, Abraham S. C, & van Deursen J. M. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J. Cell Biol. 179, 255-267 (2007).
35. Baker D. J, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat. Cell Biol. 15, 96-102 (2013).
36. Podsypanina K, et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA 96, 1563-1568 (1999).
37. Zhou W, et al. GluR1 controls dendrite growth through its binding partner, SAP97. J. Neurosci. 28, 10220-10233 (2008).
38. Ricke R. M, Jeganathan K. B, Malureanu L, Harrison A. M, & van Deursen J. M. Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression. J. Cell Biol. 199, 931-949 (2012).
39. Welburn J. P, et al. Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface. Mol. Cell 38, 383-392 (2010).
40. Eblen S. T, Fautsch M. P, Anders R. A, & Leof E. B. Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1. Cell Growth Differ. 6, 915-925 (1995).